Lucia Qian
Direktor/Vorstandsmitglied bei Affamed Therapeutics (Us), Inc.
Profil
Lucia Qian is currently a Director at Affamed Therapeutics (Us), Inc. Previously, she worked as a Director of Marketing & Investor Relations at China Nepstar Chain Drugstore Ltd.
Aktive Positionen von Lucia Qian
Unternehmen | Position | Beginn |
---|---|---|
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Lucia Qian
Unternehmen | Position | Ende |
---|---|---|
CHINA NEPSTAR CHAIN DRUGSTORE LTD.(ADR) | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
China Nepstar Chain Drugstore Ltd.
China Nepstar Chain Drugstore Ltd. Drugstore ChainsRetail Trade China Nepstar Chain Drugstore Ltd. operates as a holding company, which is engaged in the operation of retail pharmacies. It provides pharmacy services and sells prescription drugs, over the counter drugs, nutritional supplements, herbal products, personal and family care products, and convenience products. The company was founded by Si Min Zhang in June 1995 and is headquartered in Shenzhen, China. | Retail Trade |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Health Technology |